Waldemar Link Brand Guidelines: A 1948 Hamburg Implant Maker That Stayed Family-Owned

Founded in 1948, still owner-managed.

Waldemar Link, which signs itself LINK, is a Hamburg maker of artificial joints. It was founded in 1948, a date given both by the company and by the orthopaedic trade publication ORTHOWORLD, which profiled it in March 2025. The northern German life-sciences network Life Science Nord, in its member directory, says the business developed from a hospital supplies company into a global provider of joint prostheses.

The company’s own account of its origins centres on its founder. More than 75 years ago, LINK says, Waldemar Link forged a powerful bond with orthopaedic surgeons in northern Germany, and together they engineered new solutions for the problems their patients faced. The company says it has been designing and manufacturing orthopaedic implants since 1948 and that it produced its first custom implant as early as the late 1960s.

Ownership has stayed with the family. LINK describes itself as still owner-managed and still based in Hamburg, and its website lists Helmut D. Link as proprietor alongside a management team led by chief executive Peter Willenborg; its customLINK pages call it a German family-owned company. ORTHOWORLD called LINK one of the largest private independent companies in orthopaedics. Today the company describes itself as a full-line supplier, with a portfolio running from primary joint replacement to complex revision surgery of the major joints.

From revision specialist to full-line supplier.

For decades LINK was associated with the difficult cases. ORTHOWORLD described it in 2025 as a company that had moved from being a specialist in revision and oncology joint replacement implants to a full primary provider. Willenborg told the publication that the new primary portfolio for hip, knee and shoulder took about eight years to develop, with input from surgeons around the world and especially in the United States, and that it received market clearance in Europe and the US in 2021 and 2022.

Regulation has shaped the range too. Willenborg told ORTHOWORLD that LINK had received its certificates under the European Union’s Medical Device Regulation, known as MDR, after a large investment of work and money, but that some niche products could not be registered and had left the portfolio. He said the company would put a stronger focus on research projects in the United States, and that new LINK products would go to the American market first. For revision surgery he named the OptiStem, used with the company’s knee and distal femoral replacement system.

The product names carry the company’s name. The LinkSymphoKnee, which Willenborg called the company’s biggest launch in recent years, is described by LINK as a complete system running from primary total knee replacement to revision; the CORE shoulder system received US FDA 510(k) clearance, ORTHOWORLD reported; and the customLINK pages name established systems such as the LINK Endo-Model knee and the MEGASYSTEM-C modular tumour and revision system.

Custom work is a large part of the identity. The company says it has made more than 45,000 custom implants, each documented and archived, and that all of them are produced in-house in the Hamburg region; in early 2025 Willenborg put the figure at more than 40,000. Custom devices, he said, reflect a wish to offer a solution for every case, and what the company learns from them feeds into its standard implants. On surgical robotics, he said LINK develops its own technology where nothing comparable is available, as with CORE, and otherwise works with open-platform partners such as THINK Surgical in the US and OrthoKey in Europe.

How orthopaedic makers present themselves.

Orthopaedic device makers sell to a narrow, expert audience: surgeons, theatre teams, hospital buyers and the distributors who serve them. Their brand material is shaped by that audience. Product imagery tends to be precise and technical, with implants rendered as clean metallic objects, often lit against dark or neutral backgrounds so that the form of a stem, a plate or a screw reads clearly.

Clinical imagery sits alongside the renders. X-rays, bone models, anatomical cut-aways and diagrams of a joint or a spinal segment show where a device goes and how it is meant to fit. Many makers also photograph surgeons in theatre, in gowns and masks under surgical lights, and show the trays of instruments that accompany an implant system, laid out in rows that suggest order and completeness.

Education is a large part of the picture. Device makers run training courses, cadaver labs and online technique guides, and much of their visual output is instructional: step-by-step surgical technique documents, animations and videos. Congresses matter too. Large meetings such as the annual meeting of the American Academy of Orthopaedic Surgeons (AAOS) and the congress of the European Federation of National Associations of Orthopaedics and Traumatology (EFORT) are where new systems are often shown, on stands designed to carry a brand at scale.

Corporate identities in the field are usually restrained: sans-serif wordmarks, a small set of brand colours and a great deal of white space, with the visual drama left to the product and the clinical image. Many brands also sit inside larger groups, so a single name may appear alongside a parent company’s mark. That makes the typeface, the palette and the treatment of imagery the main tools a maker has for being recognised.

Cast in its own foundry, finished in Norderstedt.

Manufacturing is where LINK puts its emphasis. The company says the entire production process is in-house, from investment casting of raw implants in its own VACUCAST foundry to finishing and packaging at its plant in Norderstedt, on Hamburg’s northern edge, and that it also runs a production plant in Beijing. Willenborg told ORTHOWORLD that about 95 percent of the company’s manufacturing is done in-house, which he said helped it avoid supply-chain constraints.

Materials are part of the story it tells. LINK says it casts titanium and cobalt-chromium alloys by a proprietary investment-casting process and uses additive manufacturing for TrabecuLink, a three-dimensional structure used to compensate for bone defects or in custom-made implants. It trains surgeons through LINKademy symposiums, seminars and visiting-surgeon programmes, and trains its own staff to the German standard, combining college study with work in the company. Its development specialists work in a team the company calls DERU, and it offers 3D software for planning hip replacements before surgery.

LINK says it has locations in Brazil, Germany, Italy, Spain, Sweden, Switzerland, the United Kingdom and the United States. Its slogan, repeated across its website in capitals, is “Trust. Innovation. Progress.”

For a design guide, Waldemar Link shows how a family-owned maker can build a brand on capital-letter names and the factory floor. Compare LimaCorporate, an Italian joint-replacement maker now part of Enovis, and Stryker, an American orthopaedic group. For this guide we use a harbour navy and steel grey with a serif, an unofficial interpretation; no product or logo is reproduced.

Keep Waldemar Link’s identity on hand — save it to a board in the Made Good inspiration library.